AboutBlogOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs

EIR Anna Olak-Popko, MD, Sep 2017

$595 - Available for instant download

FDA investigators audited the Anna Olak-Popko, MD - Warsaw, Poland facility and issued inspectional observation (via FDA 483) on 19 Sep 2017.

Product Details

  • Inspection end: 19 Sep 2017
  • Location: Warsaw, Poland
  • FEI: 3013694321
Anna Olak-Popko, MD FDA inspection 483 Sep 2017